These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19966012)

  • 1. Glucose variability; does it matter?
    Siegelaar SE; Holleman F; Hoekstra JB; DeVries JH
    Endocr Rev; 2010 Apr; 31(2):171-82. PubMed ID: 19966012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?
    Saisho Y
    Int J Mol Sci; 2014 Oct; 15(10):18381-406. PubMed ID: 25314300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycaemic variability in diabetes: clinical and therapeutic implications.
    Ceriello A; Monnier L; Owens D
    Lancet Diabetes Endocrinol; 2019 Mar; 7(3):221-230. PubMed ID: 30115599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a new measure of blood glucose variability in diabetes.
    Kovatchev BP; Otto E; Cox D; Gonder-Frederick L; Clarke W
    Diabetes Care; 2006 Nov; 29(11):2433-8. PubMed ID: 17065680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Benefits of subcutaneous continuous insulin infusion in type 1 diabetic patients with high glycemic variability].
    Prieto-Tenreiro A; Villar-Taibo R; Pazos-Couselo M; González-Rodríguez M; Casanueva F; García-López JM
    Endocrinol Nutr; 2012 Apr; 59(4):246-53. PubMed ID: 22440045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should minimal blood glucose variability become the gold standard of glycemic control?
    Hirsch IB; Brownlee M
    J Diabetes Complications; 2005; 19(3):178-81. PubMed ID: 15866065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vitamin E and oxidative stress in diabetes complications.
    Pazdro R; Burgess JR
    Mech Ageing Dev; 2010 Apr; 131(4):276-86. PubMed ID: 20307566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of daily glycemic profiles in well controlled children with type 1 diabetes mellitus using a continuous glucose monitoring system.
    Tucholski K; Deja G; Skała-Zamorowska E; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2009; 15(1):29-33. PubMed ID: 19454186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous glucose monitoring and diabetes health outcomes: a critical appraisal.
    Reach G
    Diabetes Technol Ther; 2008 Apr; 10(2):69-80. PubMed ID: 18260770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemia in insulin-treated diabetes: a case for increased vigilance.
    Unger J; Parkin C
    Postgrad Med; 2011 Jul; 123(4):81-91. PubMed ID: 21680992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk.
    Gerich JE; Odawara M; Terauchi Y
    Curr Med Res Opin; 2007 Aug; 23(8):1791-8. PubMed ID: 17610805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress.
    Siegelaar SE; Kulik W; van Lenthe H; Mukherjee R; Hoekstra JB; Devries JH
    Diabetes Obes Metab; 2009 Jul; 11(7):709-14. PubMed ID: 19320663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive insulin therapy: Part I. Basic principles.
    Hirsch IB; Herter CD
    Am Fam Physician; 1992 May; 45(5):2141-7. PubMed ID: 1575109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SENSING THE BIG PICTURE WITH CONTINUOUS GLUCOSE MONITORING.
    Hieronymus L; Hepner A
    Diabetes Self Manag; 2017 Mar; 34(2):56-58. PubMed ID: 29757535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose Variability: How Does It Work?
    Klimontov VV; Saik OV; Korbut AI
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of Glucose Variability: Chronic Complications of Diabetes.
    Jung HS
    Endocrinol Metab (Seoul); 2015 Jun; 30(2):167-74. PubMed ID: 26194076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The progress of clinical research on the detection of 1,5-anhydroglucitol in diabetes and its complications.
    Xu H; Pan J; Chen Q
    Front Endocrinol (Lausanne); 2024; 15():1383483. PubMed ID: 38803475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage.
    Vivekanadan-Giri A; Wang JH; Byun J; Pennathur S
    Rev Endocr Metab Disord; 2008 Dec; 9(4):275-87. PubMed ID: 18752069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of diosgenin in diabetes and diabetic complications.
    Gan Q; Wang J; Hu J; Lou G; Xiong H; Peng C; Zheng S; Huang Q
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105575. PubMed ID: 31899316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.